GlassScriptPhysician profile
Blake Christian Leche
NPI 1770512972
$12,530.64
in general payments reported to CMS, 2019-2025
31 companies · $1,492 in 2025
The $1,492 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,152 · 2020: $1,915 · 2021: $2,048 · 2022: $2,516 · 2023: $1,869 · 2024: $1,539 · 2025: $1,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,899.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,186.79 | 2019-2025 | Proclaim, Octrode, Eterna |
| Boston Scientific Corporation | $2,908.34 | 2019-2023 | |
| Medtronic, INC. | $1,543.65 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Forte Bio-Pharma LLC | $715.91 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Medtronic USA, INC. | $581.13 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $367.24 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $144.55 | 2019-2025 | Ztlido |
| Grt US Holding, INC. | $128.69 | 2021-2022 | |
| Amgen INC. | $121.85 | 2019-2022 | |
| Nevro Corp. | $113.86 | 2021-2024 | Senza |
| Elutia, INC. | $75.35 | 2019-2022 | |
| Globus Medical, INC. | $67.13 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $66.91 | 2019-2021 | |
| Mml US, INC. | $60.41 | 2023 | Reactiv8 |
| Biodelivery Sciences International, INC. | $58.31 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $48.31 | 2020-2021 | |
| Uswm, LLC | $39.67 | 2021 | |
| Collegium Pharmaceutical, INC. | $39.50 | 2022 | |
| Orthogenrx INC. | $37.68 | 2019-2020 | |
| Redhill Biopharma INC. | $30.58 | 2020-2021 | |
| Pfizer INC. | $25.27 | 2020-2021 | |
| Mdd US Operations, LLC | $24.92 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $21.12 | 2023 | Lyvispah |
| Saluda Medical Americas, INC. | $19.20 | 2024 | Evoke |
| Protega Pharmaceutials INC | $17.33 | 2023 | Roxybond |
| Almatica Pharma LLC | $17.18 | 2023 | Gralise |
| Stryker Corporation | $15.52 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.23 | 2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $15.18 | 2025 | |
| Horizon Therapeutics Plc | $11.94 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Leche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.